Thereafter, we and other investigators confirmed the inhibitory effects of EGCG on other RTKs including erbB3/Her3, erbB4/Her4, IGFR, PDGFR, FGFR, and VEGFR employing a variety of cancer cell lines derived from different organs [33–38]. This evidence concerns the gene ERBB4 and cancer.